Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1388658 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $122.44Day +4.32%Mkt cap $4.0B1Y −10.5%Off 52W high −42.2%Vol (1Y) 45.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,450 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest10.4% of sh out |
| Days to cover5.8d |
| 13F net flow (QoQ)+6.39% |
| Top-10 13F concentration42.7% |
| Next report (est.)2026-10-29 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$787.9M |
| Earnings (TTM)-$27.8M |
| ROE−36.6% |
| Net margin−6.0% |
| Sales growth 3Y22.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−31.0% |
| 1Y−10.5% |
| 3Y+16.5% |
| 5Y+139.4% |
| Since incept. (ann.)+17.2% |
Total return through 2026-07-29 · series begins 2016-10-20. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)45.2% |
| Ann. volatility (3Y)50.9% |
| Sharpe (1Y)−0.03 |
| Sharpe (3Y)0.36 |
| Max drawdown (1Y)−46.2% |
| Max drawdown (3Y)−53.8% |
| Beta (3Y vs SPY)1.42 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 2.7M | $324M | 8.48% | −2.6% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.8M | $212M | 5.56% | new |
| RTW INVESTMENTS, LP | 1.7M | $197M | 5.16% | +41.2% |
| MILLENNIUM MANAGEMENT LLC | 1.6M | $190M | 4.98% | +94.6% |
| Artisan Partners Limited Partnership | 1.5M | $171M | 4.49% | −4.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | $171M | 4.47% | new |
| FMR LLC | 1.4M | $161M | 4.21% | +116.6% |
| Holocene Advisors, LP | 1.2M | $147M | 3.86% | +82.7% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 109.9% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 2,854,326 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-04-30 | −$0.43 | — | $199.4M | +25.7% |
| 2025-12-31 | 2026-02-19 | — | — | $208.9M | +27.1% |
| 2025-09-30 | 2025-10-30 | −$0.16 | — | $192.9M | +30.7% |
| 2025-06-30 | 2025-07-31 | −$0.44 | — | $186.7M | +26.1% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-29 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Commercial Payors 52% · Centers For Medicare And Medicaid 24% · Healthcare Institutions 17% · Non Contracted Third Party Payors 7%
product & service · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
